The USC Norris Comprehensive Cancer Center formed a collaboration with the Chinatown Service Center to improve access to life-saving cervical cancer screenings, referrals, and treatment for Chinese and Latina women in Central Los Angeles.
MD Anderson Cancer Center and World Health Organization formed an agreement to establish a new international collaboration concentrated on reducing the global burden of women’s cancers. The agreement builds on years of collaboration between the two institutions to further promote their shared efforts in advancing global cancer initiatives in women’s cancers, including breast and cervical cancers.
The Association of Community Cancer Centers named the winning programs for its 12th annual ACCC Innovator Awards, highlighting the year’s solutions to improving cancer care delivery and the patient experience. The five ACCC Innovator Award winners feature programs in areas such as remote patient monitoring, improving oral oncolytic compliance, and addressing social determinants of health.
The National Comprehensive Cancer Network received the 2022 Excellence in Cancer Patient Education award from the Cancer Patient Education Network.
Anna D. Barker, chief strategy officer at the Lawrence J. Ellison Institute for Transformative Medicine is the recipient of the AIM-HI Accelerator Fund’s inaugural Beacon Award for Women Leaders in Oncology.
The Fred C. and Katherine B. Andersen Foundation of Bayport, MN, has made a $100 million multi-year commitment to support the expansion of Mayo Clinic’s proton beam facility in Rochester to nearly double appointment access for patients.
UC Davis Comprehensive Cancer Center has established a Center for Experimental Therapeutics in Cancer to accelerate promising cancer therapies from the lab to the bedside.
Charnita Zeigler-Johnson was named associate director of community outreach and engagement at Fox Chase Cancer Center.
Joseph L. Kissil was named chair of the Molecular Oncology Department at Moffitt Cancer Center.
Moffitt Cancer Center was granted $3.7 million from NCI’s Connecting Underrepresented Populations to Clinical Trials U01 Grants Program. The five-year, $3.7 million grant will help the cancer center develop new digital tools and community outreach strategies to reach Black and Hispanic cancer patients and physicians in the Tampa Bay community.
